Evogene (EVGN) Earnings Date, Estimates & Call Transcripts

$0.66
-0.01 (-1.50%)
(As of 04/25/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 16Estimated
Actual EPS
(Mar. 7)
-$0.13 Beat By $0.01
Consensus EPS
(Mar. 7)
-$0.14
Skip Charts & View Estimated and Actual Earnings Data

EVGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EVGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

EVGN Earnings Date and Information

Evogene last issued its earnings results on March 7th, 2024. The biotechnology company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. The firm earned $0.58 million during the quarter, compared to the consensus estimate of $1.73 million. Evogene has generated ($0.53) earnings per share over the last year (($0.53) diluted earnings per share). Evogene has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 16th, 2024 based off prior year's report dates.

Evogene Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/16/2024
Estimated)
------- 
3/7/2024Q4 2023($0.14)($0.13)+$0.01($0.13)$1.73 million$0.58 million    
11/15/2023Q3 2023($0.17)($0.08)+$0.09($0.08)$1.09 million$3.77 million    
8/17/2023Q2 2023($0.19)($0.17)+$0.02($0.17)$0.77 million$0.65 million    
5/18/2023Q1 2023($0.16)($0.15)+$0.01($0.15)$0.87 million$0.64 million
3/9/2023Q4 2022($0.21)($0.07)+$0.14($0.07)$0.55 million$0.66 million
11/17/2022Q3 2022($0.20)($0.16)+$0.04($0.16)$0.26 million$0.47 million
8/31/2022Q2 2022($0.18)($0.21)($0.03)($0.21)$0.17 million$0.31 million
5/26/2022Q1 2022($0.14)($0.20)($0.06)($0.20)$0.44 million$0.24 million    
3/10/2022Q4 2021($0.20)($0.18)+$0.02($0.18)$0.15 million$0.31 million    
11/16/2021Q3 2021($0.17)($0.19)($0.02)($0.19)$0.14 million$0.15 million    
8/11/2021Q2 2021($0.18)($0.15)+$0.03($0.15)-$0.14 million    
5/25/2021Q1 2021($0.18)($0.17)+$0.01($0.17)-$0.33 million  

Evogene Earnings - Frequently Asked Questions

When is Evogene's earnings date?

Evogene has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 16th, 2024 based off last year's report dates. Learn more on EVGN's earnings history.

Did Evogene beat their earnings estimates last quarter?

In the previous quarter, Evogene (NASDAQ:EVGN) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.01. Learn more on analysts' earnings estimate vs. EVGN's actual earnings.

How can I listen to Evogene's earnings conference call?

The conference call for Evogene's latest earnings report can be listened to online. Listen to Conference Call

How can I read Evogene's conference call transcript?

The conference call transcript for Evogene's latest earnings report can be read online. Read Transcript

How much revenue does Evogene generate each year?

Evogene (NASDAQ:EVGN) has a recorded annual revenue of $5.64 million.

How much profit does Evogene generate each year?

Evogene (NASDAQ:EVGN) has a recorded net income of -$23.88 million. EVGN has generated -$0.53 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:EVGN) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners